No Data
No Data
Avidity Biosciences(RNA.US) Director Sells US$149.48K in Common Stock
$Avidity Biosciences(RNA.US)$ Director LEVIN ARTHUR A sold 5,000 shares of common stock on May 20, 2024 at an average price of $29.8962 for a total value of $149.48K.Source: Announcement What is state
Express News | Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Avidity Biosciences Poised for Growth: Buy Rating Affirmed Amidst Encouraging Competitive Landscape
PTC Therapeutics Rallies 18% on EU Authorization Update for Translarna
Bank of America Predicts up to ~200% Surge for These 2 'Strong Buy' Stocks
Avidity Biosciences Insider Sold Shares Worth $2,121,045, According to a Recent SEC Filing
Michael F MacLean, Chief Financial Officer, on May 14, 2024, sold 75,000 shares in Avidity Biosciences (RNA) for $2,121,045. Following the Form 4 filing with the SEC, MacLean has control over a total
No Data